Thymalin — references and citing documents
The full reference list for this monograph, and every Institute document that draws on it.
§10References
Every reference the monograph relies on is listed below in order of first citation across the document. Identifiers are reproduced only where the Institute holds them; where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed one.
This monograph cites 5 sources[1,2,3,4,5].
Table 9. Bibliographic records for the sources cited by this monograph. Each links to its record page, which lists every Institute document citing it.
| # | Title | Source | Year |
|---|---|---|---|
| 1 | General Chapter ⟨85⟩ Bacterial Endotoxins Test | United States Pharmacopeia — National Formulary (USP–NF) | 2024 |
| 2 | General Chapter ⟨71⟩ Sterility Tests | United States Pharmacopeia — National Formulary (USP–NF) | 2024 |
| 3 | ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories | ISO/IEC Standard | 2017 |
| 4 | WHO Expert Committee on Specifications for Pharmaceutical Preparations — Fifty-seventh report | WHO Technical Report Series | 2023 |
| 5 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ | 2021 |
§11Related Institute documents
Table 10. Institute documents that draw on, or are drawn on by, this monograph.
| Series | Count | Documents |
|---|---|---|
| Trial abstracts | 4 | THYMALIN-RU-1 · THYMALIN-RU-1-ELDERLY · THYMALIN-RU-1-OLE · THYMALIN-RU-1-ADHERENCE |
| Evidence syntheses | 2 | Nationally registered neuropeptides and the retrievability… · Thymic peptides in infection and immune support |
| Comment periods | 1 | Draft monograph: Thymalin |
| Indication assessments | 2 | Immune modulation · Ageing |
Numbered reference list
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- United States Pharmacopeial Convention. General Chapter ⟨85⟩ Bacterial Endotoxins Test. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute
- United States Pharmacopeial Convention. General Chapter ⟨71⟩ Sterility Tests. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute
- International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute
- World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations — Fifty-seventh report. WHO Technical Report Series 2023;No. 1044. identifier not held by the Institute
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi:10.1136/bmj.n71 · PMID 33782057
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.